retatrutide parkinson's disease clinical trial Liraglutide once daily versus placebo in Parkinson's disease: a randomized, double Retatrutide Explained: Mechanism & Weight

GoodRx stock soars after striking deal to sell Novo Nordisk's GLP-1s for $499/month GoodRx (GDRX) is joining in on the GLP-1 action with an announcement on Monday that it will begin selling both of Novo Nordisk's (NVO) GLP-1 drugs, Ozempic for diabetes and Wegovy for weight loss, at a cash price of $499 per month

Tailored for Tirzepatide & GLP-1 VialsStay compliant with your treatment on the go

Lipid Panel (Total Cholesterol, LDL, HDL, Triglycerides) Why it matters: Many patients initiating GLP-1 therapy have elevated triglycerides or dyslipidemia as part of their broader metabolic picture

Eur J Clin Invest 22:283291 Kreymann B, Williams G, Ghatei MA, Bloom SR (1987) Glucagon-like peptide-1 [7-36]: a physiological incretin in man

In the Prime Therapeutic study cited above, only one in four patients were still on Wegovy or Ozempic two years later

Picture GLP-1 as an interpreter between your gut and your brain: it translates Ive eaten into youre full earlier and more clearly than usual